Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-01 8:42 pm Purchase |
2023-04-27 | 13D | Vivani Medical, Inc. VANI |
Williams Gregg | 23,597,129 38.900% |
23,597,129 (New Position) |
Filing History |
| 2023-04-25 5:28 pm Purchase |
2023-04-25 | 13D | Vivani Medical, Inc. VANI |
Bolck Joachim Eberhard | 5,597,123 11.030% |
5,597,123 (New Position) |
Filing History |
| 2022-09-01 9:34 pm Purchase |
2022-08-30 | 13D | Second Sight Medical Products, Inc. EYES |
Williams Gregg | 20,909,620 41.220% |
15,145,060 (+262.73%) |
Filing History |
| 2022-08-31 6:49 pm Purchase |
2022-08-30 | 13D | Vivani Medical, Inc. VANI |
Mendelsohn Adam | 3,712,573 7.510% |
3,712,573 (New Position) |
Filing History |
| 2022-07-22 5:06 pm Purchase |
2022-05-18 | 13D | Second Sight Medical Products, Inc. EYES |
Williams Gregg | 5,764,560 38.060% |
457,653 (+8.62%) |
Filing History |
| 2022-01-13 10:36 am Sale |
2021-12-31 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 0 0.000% |
-1,100,000 (Position Closed) |
Filing History |
| 2021-06-28 10:01 am Purchase |
2021-06-22 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 1,100,000 8.710% |
1,100,000 (New Position) |
Filing History |
| 2021-02-11 4:06 pm Sale |
2020-12-31 | 13G | Second Sight Medical Products, Inc. EYES |
Altium Capital Management LLC | 0 0.000% |
-733,333 (Position Closed) |
Filing History |
| 2021-01-20 11:01 am Sale |
2020-12-31 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 0 0.000% |
-733,333 (Position Closed) |
Filing History |
| 2021-01-08 5:22 pm Purchase |
2021-01-06 | 13D | Second Sight Medical Products, Inc. EYES |
Pixium Vision S.A. | 2,326,295 30.100% |
2,326,295 (New Position) |
Filing History |
| 2021-01-05 5:08 pm Unchanged |
2020-12-31 | 13G | Second Sight Medical Products, Inc. EYES |
SABBY MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-05-08 12:04 pm Purchase |
2020-05-01 | 13G | Second Sight Medical Products, Inc. EYES |
Altium Capital Management LLC | 733,333 9.500% |
733,333 (New Position) |
Filing History |
| 2020-05-05 09:17 am Purchase |
2020-05-01 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 733,333 9.510% |
733,333 (New Position) |
Filing History |
| 2020-05-01 08:47 am Purchase |
2020-05-01 | 13G | Second Sight Medical Products, Inc. EYES |
SABBY MANAGEMENT LLC | 733,333 11.000% |
733,333 (New Position) |
Filing History |